11 Sep 2024
// PR NEWSWIRE
11 Aug 2024
// INDIANPHARMAPOST
09 Apr 2024
// PR NEWSWIRE
01 2ACITRETIN
02 3ASENAPINE MALEATE
03 2ASPIRIN; BUTALBITAL; CAFFEINE
04 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
05 1AVIBACTAM SODIUM; CEFTAZIDIME
06 2Atropine
07 1BEZAFIBRATE
08 2BRIMONIDINE TARTRATE
09 9Bimatoprost
10 1Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride
11 3Brimonidine Tartrate
12 2CHLORAMPHENICOL
13 1CHLORAMPHENICOL; PREDNISOLONE
14 1CROMOLYN SODIUM
15 1CYCLOSPORINE
16 1Clostridium botulinum neurotoxin typ A
17 3Clostridium botulinum neurotoxin type A
18 1Cyclopentolate
19 1DEXAMETHASONE
20 2DICYCLOMINE HYDROCHLORIDE
21 3DILTIAZEM HYDROCHLORIDE
22 1DIPIVEFRIN HYDROCHLORIDE
23 1Deoxycholic Acid
24 4Dexamethasone
25 1EPINASTINE HYDROCHLORIDE
26 1ESTRADIOL
27 4ETHINYL ESTRADIOL; NORETHINDRONE
28 1ETHOXZOLAMIDE
29 1Epinastine
30 1FERRIC OXYHYDROXIDE
31 4FLUOCINOLONE ACETONIDE
32 1FLUOROMETHOLONE
33 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
34 1FLURBIPROFEN SODIUM
35 1Flurbiprofen
36 1GATIFLOXACIN
37 1GENTAMICIN SULFATE
38 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
39 5HYDROCORTISONE
40 2HYDROXYPROGESTERONE CAPROATE
41 1IDOXURIDINE
42 1KETOROLAC TROMETHAMINE
43 1Ketorolac Tromethamine
44 2LEVOBUNOLOL HYDROCHLORIDE
45 6LIOTRIX (T4;T3)
46 3Levobunolol
47 2Levobunolol hydrochloride
48 2Linaclotide
49 1MEDRYSONE
50 1MEMANTINE HYDROCHLORIDE
51 12MORPHINE SULFATE
52 1NAPHAZOLINE HYDROCHLORIDE
53 4NEBIVOLOL HYDROCHLORIDE
54 1NEDOCROMIL SODIUM
55 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
56 1OFLOXACIN
57 2OXYBUTYNIN
58 2Ofloxacin
59 5OnabotulinumtoxinA
60 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
61 1PODOFILOX
62 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
63 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
64 2PROGESTERONE
65 1PROPARACAINE HYDROCHLORIDE
66 2Pilocarpine
67 1Progesterone
68 1SELENIUM SULFIDE
69 2SILODOSIN
70 3SULFACETAMIDE SODIUM
71 3Several substances refer to content
72 5TAZAROTENE
73 2TRETINOIN
74 1TRIAMCINOLONE ACETONIDE
75 3TRIMEPRAZINE TARTRATE
76 2TROSPIUM CHLORIDE
77 2Tazarotene
78 6Timolol
79 2Timolol; Bimatoprost
80 1Timolol; Brimonidine
81 2URSODIOL
82 3bimatoprost
83 1brimonidine tartrate
84 2carmellose
85 1dexametason
86 1epinastine hydrochloride
87 1pirenoxine
01 103ALLERGAN
02 14ALLERGAN HERBERT
03 3ALLERGAN INC
04 1ALLERGAN PHARMACEUT.INTERN.LTD
05 8ALLERGAN PHARMACEUTIC.IRELAND
06 14ALLERGAN SpA
07 4Allergan Pharmaceuticals (Pty) Ltd
08 12Allergan Pharmaceuticals Ireland
09 2Allergan Solvay International Limited
10 2Allergan Solvay International Ltd. (1)
11 15Allergan Solvay Ireland Ltd
12 3Allergan, Inc. Waco
01 2AEROSOL;TOPICAL
02 1Bimatoprost 0,3Mg/Ml 0.4 Ml 30Units Solution Ophthalmic Use
03 1Bimatoprost 0,3Mg/Ml 3Ml Solution Ophthalmic Use
04 1Bimatoprost 0.1Mg/Ml 3Ml Solution Ophthalmic Use
05 1Bismuth Oxide+Metronidazole+Tetracycline Hydrochloride 140+125+125Mg 120 Unita' Oral Use
06 1Brimonidine 0.2% 5Ml Solution Ophthalmic Use
07 2CAPSULE
08 17CAPSULE, EXTENDED RELEASE;ORAL
09 5CAPSULE;ORAL
10 7CREAM;TOPICAL
11 1CREAM;VAGINAL
12 2Capsule, hard
13 1Dexamethasone 700Mcg 1 Units Use Intravitreale
14 1EMULSION; OPHTHALMIC
15 6EYE DROPS, SOLUTION
16 4EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINERS
17 14Eye drops, resolution
18 1FILM, EXTENDED RELEASE;TRANSDERMAL
19 2GEL
20 1GEL, METERED;TRANSDERMAL
21 5GEL;TOPICAL
22 2GEL;VAGINAL
23 3INJECTABLE;INJECTION
24 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
25 1INTRAVITREALT IMPLANTAT I APPLIKATOR
26 1Injection fluid, resolution
27 1Intrauterine Posts
28 1Intravitrealt implant in applicator
29 1LOTION/SHAMPOO;TOPICAL
30 1Levobunolol 0.5% 0.4 Ml 60 Units Solution Ophthalmic Use
31 1Levobunolol 0.5% 5Ml Solution Ophthalmic Use
32 6OINTMENT;OPHTHALMIC
33 2OINTMENT;TOPICAL
34 2OPD
35 3POWDER FOR SOLUTION FOR INJECTION
36 1POWDER;INTRAVENOUS
37 1PULVER TILL INJEKTIONSVÄTSKA, LÖSNING
38 21SOLUTION/DROPS;OPHTHALMIC
39 1SOLUTION;ORAL
40 2SOLUTION;TOPICAL
41 3SUSPENSION/DROPS;OPHTHALMIC
42 2SUSPENSION;OPHTHALMIC
43 1SYRUP;ORAL
44 1TABLET (EXTENDED-RELEASE)
45 17TABLET;ORAL
46 2TABLET;ORAL-21
47 2TABLET;ORAL-28
48 3TABLET;SUBLINGUAL
49 1Timolol+Bimatoprost 300Mcg/Ml+5Mg/Ml 30 Joined' Solution Ophthalmic Use
50 1Timolol+Bimatoprost 900Mcg+15Mg Solution Ophthalmic Use
51 1Timolol+Bromonidine 0.2%+0.5% 5Ml Solution Ophthalmic Use
52 5VIAL; SINGLE-USE
53 14Blank
01 2-
02 20.01%
03 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
04 10.0125MG;0.0031MG
05 30.025%
06 10.025MG;0.0063MG
07 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
08 20.035MG;0.5MG
09 20.035MG;1MG
10 10.0375%
11 30.05%
12 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
13 10.05MG;0.0125MG
14 10.075%
15 10.1 MG / ML
16 20.1 mg/ml
17 60.1%
18 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 10.1%;10%
20 10.12%;0.1%
21 10.15MG;0.0375MG
22 10.1MG;0.025MG
23 10.2% (2 MG / ML)
24 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
25 20.2%;10%
26 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 10.25MG;0.0625MG
28 20.3 MG / ML
29 20.3 MG / ML + 5
30 40.3 mg/ml
31 40.3 mg/ml/5 mg/ml
32 20.3%
33 10.5 MG / ML
34 60.5%
35 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 51%
37 11%;0.5%
38 110 mg/ml
39 210%
40 110,000 UNITS/ML;EQ 1MG BASE/ML
41 1100 ALLERGAN
42 2100 UNITS/VIAL
43 1100MG
44 210MG
45 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
46 1120 cps 140 mg + 125 mg + 125 mg
47 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
48 1125MG
49 1125MG/ML
50 1130MG
51 1150MG
52 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
53 11mg/g
54 12 MG / ML + 5 MG / ML
55 22 mg/ml
56 22 mg/ml/5 mg/ml
57 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
58 22.5%
59 120 mcg/24 hours
60 1200 ALLERGAN
61 1200 UNITS/VIAL
62 1200MG
63 120MG
64 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
65 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
66 1250MG
67 1250MG/ML
68 125MG
69 2290 mcg
70 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
71 13%
72 13.9MG/24HR
73 130%
74 130MG
75 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
76 1325MG;50MG;40MG;30MG
77 14
78 14%
79 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
80 140 Monod Coll 0.4 Ml 0.03%
81 1400MG
82 140MG
83 14MG
84 150 ALLERGAN UNITS
85 250 UNITS/VIAL
86 1500MG
87 150MG
88 35mg/ml
89 160MG
90 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
91 1700 MIKROGRAM
92 1700 mcg
93 170MG
94 18%
95 180MG
96 18MG
97 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
98 1Coll 10 Ml 0.3%
99 1Coll 10 Ml 0.5%
100 2Coll 10 Ml 1%
101 1Coll 10 Ml 2%
102 1Coll 3 Ml 0.2%
103 1Coll 3 Ml 1%
104 1Coll 5 Ml 0,5 Mg/Ml
105 1Coll 5 Ml 0.1%
106 1Coll 5 Ml 0.5%
107 1Coll Bottle Groun 0.005% + Plug Solv 7 Ml
108 1EQ 0.3% BASE
109 1EQ 0.3% BASE;0.6%
110 1EQ 0.3% BASE;1%
111 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
112 1EQ 0.5GM BASE;2GM/VIAL
113 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
114 2EQ 10MG BASE
115 3EQ 2.5MG BASE
116 1EQ 2.5MG BASE/5ML
117 1EQ 20MG BASE
118 3EQ 5MG BASE
119 1EYE DROPS 3 ML 300 mcg/ml + 5 mg/ml
120 1EYE DROPS 3 ml 0,3 mg/ml
121 1EYE DROPS 3 ml 0. 1 mg/ml
122 1EYE DROPS 5 ml 0.2% + 0.5%
123 1EYE DROPS 5 ml 2 mg/ml
124 1EYE DROPS 5 ml 5 mg/ml
125 1Pom Oftalm 3,5 G 0,3%
126 1Ung Oftalm 3 G 0,2%
127 1collyrium 30 monodose containers 0.4 ml 300 mcg/ml + 5 mg/ml
128 1collyrium 30 monodose vials 0.4 ml 0,3 mg/ml
129 1collyrium 60 monodose vials 0.4 ml 5 mg/ml
130 1intravitreale implant 700 mcg + applicator
01 3Canada
02 25Italy
03 19Norway
04 4South Africa
05 15Sweden
06 115USA
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 25MG
Packaging : 30
Approval Date :
Application Number : 2070863
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 10MG
Packaging : 30
Approval Date :
Application Number : 2070847
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Packaging :
Approval Date : 2015-03-12
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 1990-10-26
Application Number : 19429
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 0.5% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 1% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
LOOKING FOR A SUPPLIER?